Studies: Adding ketamine does not help cancer pain

10/16/2012 | Medscape (free registration)

A late-stage clinical trial found that adding subcutaneous ketamine to opioids and standard coanalgesics did not improve control of cancer pain compared with a placebo, Flinders University researchers told a palliative care conference. The incidence of worsening adverse events, however, was nearly doubled among patients using ketamine compared with the placebo.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC